A challenging case of bradykinin-mediated angioedema with airway obstruction: management and therapeutic strategies
Abstract
##plugins.themes.bootstrap3.article.details##
airway obstruction, angioedema, bradykinin, histamine, icatibant, tranexamic acid
2. Debreczeni ML, Németh Z, Kajdácsi E, Farkas H, Cervenak L. Molecular Dambusters: What Is Behind Hyperpermeability in Bradykinin-Mediated Angioedema? Clin Rev Allergy Immunol. 2021;60(3):318-347. doi: 10.1007/s12016-021-08851-8. PMID: 33725263; PMCID: PMC7962090.
3. Hahn J, Hoffmann TK, Bock B, et al. Angioedema. Dtsch Arztebl Int. 2017;114(29-30):489-496. doi: 10.3238/arztebl.2017.0489. PMID: 28818177; PMCID: PMC5569554.
4. Lepelley M, Bernardeau C, Defendi F, et al. Update on bradykinin-mediated angioedema in 2020. Therapie. 2020;75(2):195-205. doi: 10.1016/j.therap.2020.02.011. PMID: 32113689.
5. Marcelino-Rodriguez I, Callero A, Mendoza-Alvarez A, et al. Bradykinin-Mediated Angioedema: An Update of the Genetic Causes and the Impact of Genomics. Front Genet. 2019;10:900. doi: 10.3389/fgene.2019.00900. Erratum in: Front Genet. 2020;11:690. PMID: 31611908; PMCID: PMC6776636.
6. Hudey SN, Westermann-Clark E, Lockey RF. Cardiovascular and Diabetic Medications That Cause Bradykinin-Mediated Angioedema. J Allergy Clin Immunol Pract. 2017;5(3):610-615. doi: 10.1016/j.jaip.2017.03.017. PMID: 28483314.
7. Busse PJ, Buckland MS. Non-histaminergic angioedema: focus on bradykinin-mediated angioedema. Clin Exp Allergy. 2013;43(4):385-94. doi: 10.1111/cea.12019. PMID: 23517034.
8. Lochbaum R, Hoffmann TK, Greve J, Hahn J. Concomitant medication in patients with bradykinin-mediated angioedema - there's more than ACE inhibitors. J Dtsch Dermatol Ges. 2023. doi: 10.1111/ddg.15154. PMID: 37483139.
9. Montinaro V, Cicardi M. ACE inhibitor-mediated angioedema. Int Immunopharmacol. 2020;78:106081. doi: 10.1016/j.intimp.2019.106081. PMID: 31835086.
10. Bartal C, Zeldetz V, Stavi V, Barski L. The role of icatibant-the B2 bradykinin receptor antagonist-in life-threatening laryngeal angioedema in the ED. Am J Emerg Med. 2015;33(3):479.e1-3. doi: 10.1016/j.ajem.2014.08.055. PMID: 25241359.
11. Bova M, Guilarte M, Sala-Cunill A, et al. Treatment of ACEI-related angioedema with icatibant: a case series. Intern Emerg Med. 2015;10(3):345-350. doi: 10.1007/s11739-015-1205-9. PMID: 25666515.
12. Wang K, Geiger H, McMahon A. Tranexamic acid for ACE inhibitor induced angioedema. Am J Emerg Med. 2021;43:292.e5-292.e7. doi: 10.1016/j.ajem.2020.10.029. PMID: 33164754.
13. Beauchêne C, Martins-Héricher J, Denis D, Martin L, Maillard H. Intérêt de l’acide tranexamique en traitement d’urgence de première intention des crises d’angiœdème bradykinique sous IEC [Tranexamic acid as first-line emergency treatment for episodes of bradykinin-mediated angioedema induced by ACE inhibitors]. Rev Med Interne. 2018;39(10):772-776. French. doi: 10.1016/j.revmed.2018.04.014. PMID: 29735174.
14. Price TM, McCoy EP. Emergency front of neck access in airway management. BJA Educ. 2019;19(8):246-253. doi: 10.1016/j.bjae.2019.04.002. PMID: 33456898; PMCID: PMC7807984.
15. Morton S, Avery P, Kua J, O'Meara M. Success rate of prehospital emergency front-of-neck access (FONA): a systematic review and meta-analysis. Br J Anaesth. 2023;130(5):636-644. doi: 10.1016/j.bja.2023.01.022. PMID: 36858888; PMCID: PMC10170392.
16. Obtułowicz K. Bradykinin-mediated angioedema. Pol Arch Med Wewn. 2016;126(1-2):76-85. doi: 10.20452/pamw.3273. PMID: 26842379.
17. Brown T, Gonzalez J, Monteleone C. Angiotensin-converting enzyme inhibitor-induced angioedema: A review of the literature. J Clin Hypertens (Greenwich). 2017;19(12):1377-1382. doi: 10.1111/jch.13097. PMID: 28994183; PMCID: PMC8031276.
18. Smolinska S, Antolín-Amérigo D, Popescu FD. Bradykinin Metabolism and Drug-Induced Angioedema. Int J Mol Sci. 2023;24(14):11649. doi: 10.3390/ijms241411649. PMID: 37511409; PMCID: PMC10380452.
19. Hasara S, Wilson K, Amatea J, Anderson J. Tranexamic Acid for the Emergency Treatment of Angiotensin-Converting Enzyme Inhibitor-Induced Angioedema. Cureus. 2021;13(9):e18116. doi: 10.7759/cureus.18116. PMID: 34692327; PMCID: PMC8525683.
Archive of Clinical Cases is protected by copyright and may be used in accordance with copyright and other applicable laws. Content available at www.clinicalcases.eu and our digital applications is intended for personal noncommercial use.
Authors who submit a manuscript for publication in Archive of Clinical Cases agree to the following terms: a. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal. b. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal. c. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) only after the final version of the manuscript was accepted and published, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access). d. It is compulsory that before submission authors ensure that their work was not published in any other medical journals or pending acceptance for publication and that "Archives of Clinical Cases" is the only beneficiary at that moment if their work/case will be accepted by us.
Guidelines for linking to www.clinicalcases.eu a. The main purpose of the site linking to the Archive of Clinical Cases’s site should be educational. b. Links should be made to the Archive of Clinical Cases’s home page (www.clinicalcases.eu) or to the article’s abstract. c. It is forbidden to use the Archive of Clinical Cases’s cover by outside organizations unless permission has been granted in advance, notifying our Secretary. d. Material owned by the Archive of Clinical Cases (including the name, logo, cover, and text) may not be used in any manner that may induce the idea or suggest that the Archive of Clinical Cases is in some way recommending a specific company, product or service. e. You must not use or allow others to access or use, all or any part of our Site or the contents and/or applications on it for commercial purposes without our permission. To seek permission to do anything prohibited by or not contained in these TERMS, or which requires our prior consent or agreement, you can contact us.